Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Office Of Drug Safety Director Is Surveillance Division Head Gerald Dal Pan

This article was originally published in The Pink Sheet Daily

Executive Summary

Appointment of the Division of Surveillance, Research & Communication Support director as permanent director of the Office of Drug Safety ends a two-year vacancy.

You may also be interested in...



CDER Reorganization Will Create Center-Level Associate Director For Safety

Proposed realignment also will include a new office to serve as a nexus for FDA's Critical Path initiatives.

CDER Reorganization Will Create Center-Level Associate Director For Safety

Proposed realignment also will include a new office to serve as a nexus for FDA's Critical Path initiatives.

Help Wanted: FDA Seeks Drug Safety Office Director

Requirements for the position include a medical degree and “advanced knowledge” of epidemiology, public health issues related to drug safety and risk management, the job description says. The agency is undertaking a nationwide search to fill the post; application materials are due by July 27.

Topics

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel